Thursday 26 September is the inaugural Childhood Brain Cancer Awareness Day. This year, we shine a light on Diffuse Intrinsic Pontine Glioma (DIPG), the most devastating of all childhood cancers.
Ten of our researchers spent a successful and productive two days at the Sydney Cancer Conference at Darling Harbour last week. The work they presented was very well-received, with two speakers carrying off prizes.
This week we’re looking at Drug Discovery – the development of new cancer treatments. Because it’s only with more effective, less toxic cancer drugs that we’ll be able to save the life of every child with cancer and improve their long-term health.
On Tuesday, 40 school students from Canberra visited us to learn about cancer and how we’re working to cure it. For the budding scientists among them, it was a chance to find out what a career in medical research is really like.
Brain cancers are the leading disease-related cause of death in Australian children. In this article, first published in The Conversation, A/Prof David Ziegler explains what we can learn from improving childhood leukaemia survival.
Brain tumours are among the deadliest childhood cancers and Diffuse Intrinsic Pontine Glioma (DIPG) one of the most aggressive. But we’re making progress in the search for effective treatments.
In the second post in a series profiling our emerging researchers, we meet Dr Han Shen who's researching treatments for children with a terrible cancer.
An award for our brain cancer team recognises research into one of the nastiest childhood cancers. Our team will test potential new treatments on tiny soccer balls of cells.
Children’s cancers are a focus for three priority-driven research grants announced this week by Cancer Australia.
Showing it's not just genes that get promoted, we congratulate two of our research leaders for their promotion as UNSW academics, a tribute to their significant research achievements.